Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Infanrix/Hib Booster in 18-24 Month Old Children
NCT00696423Phase 3Completed
- Sponsor
- GSK
- Start
- Jun 2008
- Primary completion
- Jul 2008
- Modality
- Split/Subunit Vaccines
- Countries
- 1
01
Overview
A Phase 3 trial of Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated), Haemophilus b conjugate vaccine in diphtheria, Tetanus, pertussis, Haemophilus influenzae type b infection (Hib), sponsored by GSK. Started Jun 2008; status: completed.
02
Drugs
Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated)Haemophilus b conjugate vaccine
03
Conditions
diphtheriaTetanuspertussisHaemophilus influenzae type b infection (Hib)
Beyond the preview
Go deeper on NCT00696423.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00696423.